FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071602104> ?p ?o ?g. }

• W2071602104 endingPage "203" @default.
• W2071602104 startingPage "197" @default.
• W2071602104 abstract "Abstract Administration of immunosuppressive treatment in hepatitis B virus carriers with malignancies is associated with the risk of hepatitis B reactivation. This complication is more frequent in patients with hematologic malignancies because administration of corticosteroids, the mainstay of treatment of these patients, is an independent risk factor for hepatitis B reactivation. When lamivudine is given prior to chemotherapy, it prevents the viral replication during the immunosuppression period; therefore, it might reduce the risk of hepatitis B exacerbation. We performed a prospective study to assess the efficacy of prophylactic administration of lamivudine in this setting. Ten hepatitis B virus carriers with hematologic malignancies were included in this study; seven were HBsAg positive, and three had isolated antiHBc and detectable HBV‐DNA levels. Nine patients were given corticosteroids after the administration of lamivudine. Lamivudine was given per os at a dose of 100 mg once daily. In four patients that had not been previously treated with chemotherapy, lamivudine was started 19 days (median) (range, 0–35 days) prior to the onset of chemotherapy. The administration of lamivudine has not stopped since in any of our patients. After a median follow‐up of 15 months (range 6–38 months), no hepatitis B reactivation was observed. HBV‐DNA levels were decreased in all 6 patients who had detectable HBV‐DNA at baseline. Lamivudine was well tolerated. Chemotherapy regimens were administered as planned, and their effectiveness was not compromised by lamivudine. In conclusion, prophylactic administration of lamivudine should be considered as a means of reducing the frequency of hepatitis B reactivation in hepatitis B virus carriers with hematologic malignancies who are being treated with chemotherapy. Am. J. Hematol. 80:197–203, 2005. © 2005 Wiley‐Liss, Inc." @default.
• W2071602104 created "2016-06-24" @default.
• W2071602104 creator A5002663610 @default.
• W2071602104 creator A5019121947 @default.
• W2071602104 creator A5021164432 @default.
• W2071602104 creator A5043909538 @default.
• W2071602104 creator A5066523341 @default.
• W2071602104 creator A5076157401 @default.
• W2071602104 date "2005-10-24" @default.
• W2071602104 modified "2023-10-17" @default.
• W2071602104 title "Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy—A prospective case series" @default.
• W2071602104 cites W1813391014 @default.
• W2071602104 cites W1967577450 @default.
• W2071602104 cites W1967673861 @default.
• W2071602104 cites W1973259257 @default.
• W2071602104 cites W1983039036 @default.
• W2071602104 cites W1985577568 @default.
• W2071602104 cites W1989712687 @default.
• W2071602104 cites W1990335264 @default.
• W2071602104 cites W1993368800 @default.
• W2071602104 cites W1996775636 @default.
• W2071602104 cites W2010214661 @default.
• W2071602104 cites W2021698494 @default.
• W2071602104 cites W2021894610 @default.
• W2071602104 cites W2029447838 @default.
• W2071602104 cites W2030093486 @default.
• W2071602104 cites W2030841386 @default.
• W2071602104 cites W2031500470 @default.
• W2071602104 cites W2038938604 @default.
• W2071602104 cites W2040719842 @default.
• W2071602104 cites W2043258786 @default.
• W2071602104 cites W2047730891 @default.
• W2071602104 cites W2065598785 @default.
• W2071602104 cites W2069827257 @default.
• W2071602104 cites W2070268111 @default.
• W2071602104 cites W2072210000 @default.
• W2071602104 cites W2073559033 @default.
• W2071602104 cites W2074433769 @default.
• W2071602104 cites W2075885812 @default.
• W2071602104 cites W2080156814 @default.
• W2071602104 cites W2083629462 @default.
• W2071602104 cites W2094197321 @default.
• W2071602104 cites W2096895966 @default.
• W2071602104 cites W2105403730 @default.
• W2071602104 cites W2106197507 @default.
• W2071602104 cites W2109565801 @default.
• W2071602104 cites W2281527787 @default.
• W2071602104 cites W2338794667 @default.
• W2071602104 cites W2401812034 @default.
• W2071602104 cites W2979890205 @default.
• W2071602104 cites W3152231134 @default.
• W2071602104 cites W4234848984 @default.
• W2071602104 cites W4362208329 @default.
• W2071602104 cites W56605606 @default.
• W2071602104 cites W2092236638 @default.
• W2071602104 doi "https://doi.org/10.1002/ajh.20471" @default.
• W2071602104 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16247746" @default.
• W2071602104 hasPublicationYear "2005" @default.
• W2071602104 type Work @default.
• W2071602104 sameAs 2071602104 @default.
• W2071602104 citedByCount "43" @default.
• W2071602104 countsByYear W20716021042012 @default.
• W2071602104 countsByYear W20716021042014 @default.
• W2071602104 countsByYear W20716021042015 @default.
• W2071602104 countsByYear W20716021042016 @default.
• W2071602104 countsByYear W20716021042020 @default.
• W2071602104 countsByYear W20716021042021 @default.
• W2071602104 crossrefType "journal-article" @default.
• W2071602104 hasAuthorship W2071602104A5002663610 @default.
• W2071602104 hasAuthorship W2071602104A5019121947 @default.
• W2071602104 hasAuthorship W2071602104A5021164432 @default.
• W2071602104 hasAuthorship W2071602104A5043909538 @default.
• W2071602104 hasAuthorship W2071602104A5066523341 @default.
• W2071602104 hasAuthorship W2071602104A5076157401 @default.
• W2071602104 hasBestOaLocation W20716021041 @default.
• W2071602104 hasConcept C126322002 @default.
• W2071602104 hasConcept C159047783 @default.
• W2071602104 hasConcept C203014093 @default.
• W2071602104 hasConcept C2522874641 @default.
• W2071602104 hasConcept C2776694085 @default.
• W2071602104 hasConcept C2777382497 @default.
• W2071602104 hasConcept C2777410769 @default.
• W2071602104 hasConcept C2777869810 @default.
• W2071602104 hasConcept C2780252810 @default.
• W2071602104 hasConcept C2780593183 @default.
• W2071602104 hasConcept C71924100 @default.
• W2071602104 hasConcept C90924648 @default.
• W2071602104 hasConceptScore W2071602104C126322002 @default.
• W2071602104 hasConceptScore W2071602104C159047783 @default.
• W2071602104 hasConceptScore W2071602104C203014093 @default.
• W2071602104 hasConceptScore W2071602104C2522874641 @default.
• W2071602104 hasConceptScore W2071602104C2776694085 @default.
• W2071602104 hasConceptScore W2071602104C2777382497 @default.
• W2071602104 hasConceptScore W2071602104C2777410769 @default.
• W2071602104 hasConceptScore W2071602104C2777869810 @default.
• W2071602104 hasConceptScore W2071602104C2780252810 @default.
• W2071602104 hasConceptScore W2071602104C2780593183 @default.
• W2071602104 hasConceptScore W2071602104C71924100 @default.

• next